Acrivon Therapeutics, Inc. Common Stock

General ticker "ACRV" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $152.7M (TTM average)

Acrivon Therapeutics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -1.1%.

Estimated limits based on current volatility of 5.2%: low 2.18$, high 2.42$

Factors to consider:

  • Total employees count: 41 as of 2022
  • Current price 47.9% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.15$, 10.74$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.57$, 9.45$]

Financial Metrics affecting the ACRV estimates:

  • Negative: with PPE of -2.6 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -3.11 <= 0.33
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Net income
  • Positive: -4.48 < Investing cash flow per share per price, % of -2.45

Similar symbols

Short-term ACRV quotes

Long-term ACRV plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $32.66MM $67.24MM $89.20MM
Operating Income $-32.66MM $-67.24MM $-89.20MM
Non-Operating Income $1.49MM $6.85MM $8.64MM
R&D Expense $23.95MM $45.49MM $63.99MM
Income(Loss) $-31.17MM $-60.39MM $-80.56MM
Profit(Loss)* $-31.17MM $-60.39MM $-80.56MM
Stockholders Equity $170.47MM $121.19MM $176.79MM
Assets $181.23MM $138.26MM $196.59MM
Operating Cash Flow $-30.12MM $-42.64MM $-65.67MM
Capital expenditure $2.17MM $1.29MM $2.77MM
Investing Cash Flow $-141.68MM $50.72MM $-51.77MM
Financing Cash Flow $101.71MM $-1.55MM $121.03MM
Earnings Per Share** $-1.42 $-2.74 $-2.10

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.